Big Bug Is Collapsing — After Burning Through Billions That Could Have Supported Real Agriculture

For years, insect protein companies promised to revolutionize the food system. Investors poured billions into the sector. Governments offered subsidies and grants. Policymakers were told insect farming would be cheaper, greener, and inevitable.

But reality is now catching up.

Across Europe and North America, major insect protein companies are restructuring, downsizing, pausing projects, or collapsing outright. What was marketed as the “future of food” is increasingly looking like a cautionary tale about hype, speculative investment, and misplaced public funding.

The flagship companies are struggling or failing

The most prominent example is French insect-protein giant Ÿnsect, once considered the global leader in the industry. After raising more than €500–600 million in public and private funding, the company entered insolvency proceedings and was ultimately placed into liquidation in 2025 after failing to secure enough financing to continue operations.

Despite massive fundraising, the company struggled with the basic economics of scaling insect protein production. High capital costs and limited market demand ultimately proved fatal to its business model.

The company’s financials illustrate the gap between hype and reality: in one year it generated only a few million euros in revenue while posting tens of millions in losses.

Ÿnsect is not an isolated example. Other insect agriculture ventures have also faced financial distress, restructuring efforts, or delayed expansion plans as investors reassess the sector’s viability.

Billions invested — with little to show

Over the past decade, more than $2 billion flowed into insect protein startups globally. But the expected transformation of the protein market has not materialized.

Several structural problems have emerged:

• Production costs remain higher than conventional feed ingredients
• Energy requirements for climate-controlled insect facilities are significant
• Demand has been weaker than projected
• Many projects depend on continued investor subsidies rather than market profitability

Some large projects have been paused or abandoned entirely as companies struggle to make the economics work.

Even surviving companies are often pivoting away from ambitious food system transformation claims toward niche markets like pet food or fertilizer.

Taxpayer exposure raises accountability concerns

Public funding has also played a role in supporting insect protein ventures through grants, development programs, and innovation financing.

For example, government funding has supported insect agriculture demonstration projects and fertilizer initiatives tied to insect production.

This raises legitimate public policy questions:

Should taxpayers be underwriting speculative food technologies that have not demonstrated economic viability?

Should public agricultural funding prioritize experimental protein startups over established farmers facing real economic pressures?

Should governments be picking winners in emerging food markets at all?

These questions become more pressing as projects fail or require restructuring after receiving public support.

Meanwhile, heritage agriculture struggles for support

While billions have flowed into insect startups, many traditional livestock producers continue to operate on thin margins while facing rising regulatory costs, land pressures, and input price volatility.

Regardless of one’s dietary views, conventional agriculture remains the backbone of food production. Yet investment priorities in recent years have often favored speculative “disruption” narratives rather than strengthening proven food systems.

This creates a basic policy tradeoff question:

Should scarce agricultural investment be directed toward experimental protein sectors—or toward improving the resilience, efficiency, and sustainability of existing food production systems?

The economics of insect protein remain uncertain

The core problem facing the insect protein industry appears to be economic rather than ideological.

The central promise was simple:

Insects would provide cheaper, scalable protein.

Instead, companies have encountered:

• High infrastructure costs
• Expensive automation requirements
• Complex biological production challenges
• Difficulty competing with soy, fishmeal, and conventional animal proteins

These are not temporary growing pains. They are structural cost challenges.

And markets are responding accordingly.

Innovation should not mean ignoring economic reality

Food innovation plays an important role in agricultural progress. But innovation must ultimately succeed on safety, transparency, and economics—not marketing narratives.

The recent wave of restructurings and bankruptcies suggests the sector may have expanded faster than market fundamentals justified.

That does not mean insect protein disappears. It likely means the sector becomes smaller, more specialized, and more grounded in realistic use cases.

But it does suggest policymakers should be cautious about treating emerging protein trends as inevitable revolutions.

The bottom line

The story of insect protein is not just about bugs. It is about how food policy priorities are set.

Billions in investment chased a vision that has yet to demonstrate large-scale viability.

Major companies have collapsed.

Projects have stalled.

Markets have cooled.

Meanwhile, the farmers who actually feed the world continue to face economic pressure with far less attention.

Innovation deserves scrutiny. Public funding deserves accountability. And agricultural policy should prioritize proven food systems before subsidizing speculative ones.

If insect protein ultimately succeeds, it should succeed on its own merits—not on hype, subsidies, or assumptions about inevitability.